BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15752238)

  • 1. Genetics of common progressive renal disease.
    Chow KM; Wong TY; Li PK
    Kidney Int Suppl; 2005 Apr; (94):S41-5. PubMed ID: 15752238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgA nephropathy: the presence of familial disease does not confer an increased risk for progression.
    Izzi C; Ravani P; Torres D; Prati E; Viola BF; Guerini S; Foramitti M; Frascà G; Amoroso A; Ghiggeri GM; Schena FP; Scolari F
    Am J Kidney Dis; 2006 May; 47(5):761-9. PubMed ID: 16632014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic initiation of hypertensive and diabetic nephropathy.
    Freedman BI; Bowden DW; Rich SS; Appel RG
    Am J Hypertens; 1998 Feb; 11(2):251-7. PubMed ID: 9524057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The DD genotype of the ACE gene polymorphism is associated with progression of diabetic nephropathy to end stage renal failure in IDDM.
    Vleming LJ; van der Pijl JW; Lemkes HH; Westendorp RG; Maassen JA; Daha MR; van Es LA; van Kooten C
    Clin Nephrol; 1999 Mar; 51(3):133-40. PubMed ID: 10099885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics of progressive renal failure in diabetic kidney disease.
    Liu Y; Freedman BI
    Kidney Int Suppl; 2005 Dec; (99):S94-7. PubMed ID: 16336585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Disease susceptibility genes related to kidney diseases, with special reference to SNPs].
    Maruyama H; Kondo D; Gesho F
    Nihon Naika Gakkai Zasshi; 2005 Aug; 94(8):1632-9. PubMed ID: 16190349
    [No Abstract]   [Full Text] [Related]  

  • 7. MicroRNAs in kidney physiology and disease.
    Trionfini P; Benigni A; Remuzzi G
    Nat Rev Nephrol; 2015 Jan; 11(1):23-33. PubMed ID: 25385286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic factors in diabetic nephropathy.
    Freedman BI; Bostrom M; Daeihagh P; Bowden DW
    Clin J Am Soc Nephrol; 2007 Nov; 2(6):1306-16. PubMed ID: 17942768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventing end stage renal disease in diabetic patients--genetic aspect (part I).
    Jacobsen PK
    J Renin Angiotensin Aldosterone Syst; 2005 Mar; 6(1):1-14. PubMed ID: 16088846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome study of kidney disease in the age of post genome-sequencing.
    Doi K; Okamoto K; Tokunaga K; Fujita T; Noiri E
    Endocr Metab Immune Disord Drug Targets; 2008 Sep; 8(3):173-83. PubMed ID: 18782013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for subclinical nephropathy in relatives of dialysis patients.
    Satko SG; Freedman BI
    Semin Dial; 2001; 14(5):311-3. PubMed ID: 11679093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of interferon-gamma and interleukin-4 gene polymorphisms on development and progression of IgA nephropathy in Japanese patients.
    Masutani K; Miyake K; Nakashima H; Hirano T; Kubo M; Hirakawa M; Tsuruya K; Fukuda K; Kanai H; Otsuka T; Hirakata H; Iida M
    Am J Kidney Dis; 2003 Feb; 41(2):371-9. PubMed ID: 12552499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid Biopsy: A New Avenue for the Diagnosis of Kidney Disease: Diabetic Kidney Disease, Renal Cancer, and IgA Nephropathy.
    Dybiec J; Frąk W; Kućmierz J; Tokarek J; Wojtasińska A; Młynarska E; Rysz J; Franczyk B
    Genes (Basel); 2024 Jan; 15(1):. PubMed ID: 38254967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphisms of the renin-angiotensin-aldosterone system in end-stage renal disease.
    Lovati E; Richard A; Frey BM; Frey FJ; Ferrari P
    Kidney Int; 2001 Jul; 60(1):46-54. PubMed ID: 11422735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of cytokine gene polymorphisms for the development of end-stage renal disease.
    Babel N; Gabdrakhmanova L; Hammer MH; Schoenemann C; Skrypnikov V; Poliak N; Volk HD; Reinke P
    J Nephrol; 2006; 19(6):802-7. PubMed ID: 17173255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C4A deficiency and poor prognosis in patients with IgA nephropathy.
    Wyatt RJ; Julian BA; Woodford SY; Wang C; Roberts J; Thompson JS; Christenson MJ; McLean RH
    Clin Nephrol; 1991 Jul; 36(1):1-5. PubMed ID: 1889146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial clustering of chronic kidney disease.
    Satko SG; Sedor JR; Iyengar SK; Freedman BI
    Semin Dial; 2007; 20(3):229-36. PubMed ID: 17555489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CC-chemokine receptor five gene polymorphism in primary IgA nephropathy: the 32 bp deletion allele is associated with late progression to end-stage renal failure with dialysis.
    Berthoux FC; Berthoux P; Mariat C; Thibaudin L; Afiani A; Linossier MT
    Kidney Int; 2006 Feb; 69(3):565-72. PubMed ID: 16395252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing genetic susceptibility to diabetic nephropathy.
    Tanaka N; Babazono T
    Nephrology (Carlton); 2005 Oct; 10 Suppl():S17-21. PubMed ID: 16174281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis and treatment of chronic kidney disease: a review of our recent basic and clinical data.
    Tomino Y
    Kidney Blood Press Res; 2014; 39(5):450-89. PubMed ID: 25501571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.